Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May;32(5):3416-3428.
doi: 10.1245/s10434-024-16788-3. Epub 2024 Dec 28.

Perioperative Benzodiazepine Exposure Impacts Risk of New Persistent Benzodiazepine Use Among Patients with Cancer

Affiliations

Perioperative Benzodiazepine Exposure Impacts Risk of New Persistent Benzodiazepine Use Among Patients with Cancer

Zayed Rashid et al. Ann Surg Oncol. 2025 May.

Abstract

Background: Benzodiazepines are the third most misused medication, with many patients having their first exposure during a surgical episode. We sought to characterize factors associated with new persistent benzodiazepine use (NPBU) among patients undergoing cancer surgery.

Patients and methods: Patients who underwent cancer surgery between 2013 and 2021 were identified using the IBM-MarketScan database. NPBU was defined as one prescription filled during the 90-180 days period after surgery by patients who were previously benzodiazepine naïve. The association of variables with perioperative benzodiazepine use and NPBU was assessed using multivariable regression.

Results: Among 34,637 patients with cancer (breast: n = 5460, 15.8%; lung: n = 3479, 10.0%; esophagus: n = 384, 1.1%; gastric: n = 852, 2.5%; liver: n =502, 1.4%; biliary: n = 268, 0.8%; pancreas: n = 1290, 3.7%; colon: n = 10,838, 31.3%; rectum: n = 2566, 7.4%; prostate: n = 8998, 26.0%), most were male (n = 19,687, 56.8%) with a median age of 57 years (IQR 51-61 years). Overall, 8.8% of patients had perioperative benzodiazepine use and 7.5% of patients developed NPBU following surgery. On multivariable analyses, perioperative benzodiazepine exposure (ref. no perioperative exposure: OR 2.00, 95% CI 1.68-2.38) and higher perioperative dose of > 32.0 lorazepam milligram equivalents (LME) (ref. < 10 LME: OR 2.42, 95% CI 2.01-2.92) were independently associated with higher odds of NPBU. Notably, male patients had lower odds of NPBU versus female patients (OR 0.80, 95% CI 0.68-0.94).

Conclusions: Roughly 1 in 13 commercially insured patients developed NPBU following surgery for cancer. Judicious use of benzodiazepines among patients with high risk of misuse can mitigate NPBU to help avoid benzodiazepine-related complications such as overdose or accidental deaths.

Keywords: Chemoradiotherapy; Lorazepam milligram equivalents; Misuse; Prescription drugs; Temporal trends.

PubMed Disclaimer

Conflict of interest statement

Disclosures: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. The authors declare no funding or financial support. The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Khalil M, Woldesenbet S, Munir MM, et al. Long-term health outcomes of new persistent opioid use after gastrointestinal cancer surgery. Ann Surg Oncol. 2024;31(8):5283–92. https://doi.org/10.1245/s10434-024-15435-1 . - DOI - PMC - PubMed
    1. Wilson N. Drug and opioid-involved overdose deaths—United States, 2017–2018. MMWR Morb Mortal Wkly Rep. 2020. https://doi.org/10.15585/mmwr.mm6911a4 . - DOI - PMC - PubMed
    1. Votaw VR, Geyer R, Rieselbach MM, McHugh RK. The epidemiology of benzodiazepine misuse: a systematic review. Drug Alcohol Depend. 2019;200:95–114. https://doi.org/10.1016/j.drugalcdep.2019.02.033 . - DOI - PMC - PubMed
    1. Bachhuber MA, Hennessy S, Cunningham CO, Starrels JL. Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996–2013. Am J Public Health. 2016;106(4):686–8. https://doi.org/10.2105/AJPH.2016.303061 . - DOI - PMC - PubMed
    1. Peng L, Meeks TW, Blazes CK. Complex persistent benzodiazepine dependence—when benzodiazepine deprescribing goes awry. JAMA Psychiatry. 2022;79(7):639–40. https://doi.org/10.1001/jamapsychiatry.2022.1150 . - DOI - PubMed

Substances

LinkOut - more resources